Discover the key opportunities and investments for enhancing regional pharmaceutical capacity to advance affordable, quality medication and innovative treatments in our paper, ‘Redefining Regional Pharma’.
The global pharmaceutical industry is increasingly realizing the value of a more agile and resilient supply chain model.The UAE has positioned itself as a regional hub for the pharmaceutical industry and created an environment conducive to sustainable growth.To ensure the UAE’s pharmaceutical industry reaches its full potential, establishing a life sciences R&D ecosystem, developing biotech and life sciences parks, and increasing manufacturing capabilities will be among the critical components.
DOWNLOAD THE PAPERDOWNLOAD THE PAPERBilateral relationships need to continue to be leveraged to foster investment in clinical research that addresses local and regional healthcare needs. By establishing cooperation between the public and private sectors and academia, public health programs and research can be more robust.
Technological advances offer the potential for the UAE to reduce its reliance on importing medical equipment and products. For example, UAE universities are exploring the potential for 3D printing. Two Mechanical Engineering students from Khalifa University presented a lower limb prosthetic manufactured using 3D printing at Innovator 2020 in Abu Dhabi, which costs less than $1,000 to print and can be produced in 48 hours.
The complexity of pharmaceuticals and life sciences elevates the importance of having a deep talent pool. DoH recently announced a collaboration with Pfizer to train up to 150 clinical researchers within two years. In addition, the UAE has launched the “Projects of the 50” initiative that aims to bring 10,000 UAE Nationals into the medical field in the next five years via scholarships in various healthcare disciplines.